Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 1
2006 4
2007 4
2008 5
2009 5
2010 12
2011 24
2012 9
2013 11
2014 8
2015 20
2016 20
2017 10
2018 21
2019 19
2020 13
2021 22
2022 27
2023 18
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Results by year

Filters applied: . Clear all
Page 1
A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide.
Crossnohere NL, Anderson N, Baumhauer J, Calvert M, Esparza R, Gulbransen S, Haverman L, Li Y, Petersen C, Retzer A, Sidey-Gibbons C, Stover AM, Thorner E, Ursin G, Velikova G, Walker ES, Brundage M, Snyder C. Crossnohere NL, et al. Among authors: velikova g. Nat Med. 2024 Apr 16. doi: 10.1038/s41591-024-02909-8. Online ahead of print. Nat Med. 2024. PMID: 38627558 No abstract available.
The evolving value assessment of cancer therapies: Results from a modified Delphi study.
Lee M, Larose H, Gräbeldinger M, Williams J, Baird AM, Brown S, Bruns J, Clark R, Cortes J, Curigliano G, Ferris A, Garrison LP, Gupta YK, Kanesvaran R, Lyman G, Pani L, Pemberton-Whiteley Z, Salmonson T, Sawicki P, Stein B, Suh DC, Velikova G, Grueger J. Lee M, et al. Among authors: velikova g. Health Policy Open. 2024 Mar 1;6:100116. doi: 10.1016/j.hpopen.2024.100116. eCollection 2024 Dec. Health Policy Open. 2024. PMID: 38464704 Free PMC article.
Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy.
Dawkins B, Absolom K, Hewison J, Warrington L, Hudson E, Holch P, Carter R, Gibson A, Holmes M, Rogers Z, Dickinson S, Morris C, Woroncow B, Brown J, Hulme C, Velikova G. Dawkins B, et al. Among authors: velikova g. JCO Oncol Pract. 2024 Apr;20(4):581-590. doi: 10.1200/OP.23.00498. Epub 2024 Jan 24. JCO Oncol Pract. 2024. PMID: 38266205 Free article. Clinical Trial.
Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes-Based Prognostic and Predictive Models in Cancer Clinical Practice.
Spencer KL, Absolom KL, Allsop MJ, Relton SD, Pearce J, Liao K, Naseer S, Salako O, Howdon D, Hewison J, Velikova G, Faivre-Finn C, Bekker HL, van der Veer SN. Spencer KL, et al. Among authors: velikova g. JCO Clin Cancer Inform. 2023 Sep;7:e2300070. doi: 10.1200/CCI.23.00070. JCO Clin Cancer Inform. 2023. PMID: 37976441 Free article.
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).
Vasudev NS, Ainsworth G, Brown S, Pickering L, Waddell T, Fife K, Griffiths R, Sharma A, Katona E, Howard H, Velikova G, Maraveyas A, Brown J, Pezaro C, Tuthill M, Boleti E, Bahl A, Szabados B, Banks RE, Brown J, Venugopal B, Patel P, Jain A, Symeonides SN, Nathan P, Collinson FJ, Powles T. Vasudev NS, et al. Among authors: velikova g. J Clin Oncol. 2024 Jan 20;42(3):312-323. doi: 10.1200/JCO.23.00236. Epub 2023 Nov 6. J Clin Oncol. 2024. PMID: 37931206 Free PMC article. Clinical Trial.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Velikova G, Morden JP, Haviland JS, Emery C, Barrett-Lee P, Earl H, Bloomfield D, Brunt AM, Canney P, Coleman R, Verrill M, Wardley A, Bertelli G, Ellis P, Stein R, Bliss JM, Cameron D; TACT2 Trial Management Group. Velikova G, et al. Lancet Oncol. 2023 Dec;24(12):1359-1374. doi: 10.1016/S1470-2045(23)00460-6. Epub 2023 Nov 2. Lancet Oncol. 2023. PMID: 37926100 Free article. Clinical Trial.
222 results